201 related articles for article (PubMed ID: 19450571)
1. Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2.
Guo L; Song L; Wang Z; Zhao W; Mao W; Yin M
Chem Biol Interact; 2009 Sep; 181(1):138-43. PubMed ID: 19450571
[TBL] [Abstract][Full Text] [Related]
2. [Induction of differentiation by ginsenoside Rh2 in hepatocarcinoma cell SMMC-7721].
Zeng XL; Tu ZG
Ai Zheng; 2004 Aug; 23(8):879-84. PubMed ID: 15301707
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in rat C6 glioma cells by panaxydol.
Hai J; Lin Q; Lu Y; Zhang H; Yi J
Cell Biol Int; 2007 Jul; 31(7):711-5. PubMed ID: 17320424
[TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation by panaxydol in human hepatocarcinoma SMMC-7721 cells via cAMP and MAP kinase dependent mechanism.
Wang ZJ; Song L; Guo LC; Yin M; Sun YN
Yakugaku Zasshi; 2011; 131(6):993-1000. PubMed ID: 21628989
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition and induction of differentiation by panaxydol in rat C6 glioma cells.
Hai J; Lin Q; Lu Y; Yi J; Zhang H
Neurol Res; 2008 Feb; 30(1):99-105. PubMed ID: 17767808
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells.
Lin CP; Liu JD; Chow JM; Liu CR; Liu HE
Anticancer Drugs; 2007 Feb; 18(2):161-70. PubMed ID: 17159602
[TBL] [Abstract][Full Text] [Related]
7. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM
Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase activity is required for the induction of differentiation in C6 glioma cells by panaxydol.
Hai J; Lin Q; Lu Y
J Clin Neurosci; 2009 Mar; 16(3):444-8. PubMed ID: 19179079
[TBL] [Abstract][Full Text] [Related]
9. Effects of sodium phenylbutyrate on differentiation and induction of the P21WAF1/CIP1 anti-oncogene in human liver carcinoma cell lines.
Meng M; Jiang JM; Liu H; In CY; Zhu JR
Chin J Dig Dis; 2005; 6(4):189-92. PubMed ID: 16246228
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP-dependent regulation of differentiation of rat C6 glioma cells by panaxydol.
Hai J; Lin Q; Zhang H; Lu Y; Yi J
Neurol Res; 2009 Apr; 31(3):274-9. PubMed ID: 19040798
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro.
Xia D; Yan LN; Xie JG; Tong Y; Yan ML; Wang XP; Zhang MM; Zhao LY
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):409-15. PubMed ID: 16911941
[TBL] [Abstract][Full Text] [Related]
12. Panaxydol Derived from Panax ginseng Inhibits G
Lee JH; Leem DG; Chung KS; Kim KT; Choi SY; Lee KT
Biol Pharm Bull; 2018; 41(11):1701-1707. PubMed ID: 30381670
[TBL] [Abstract][Full Text] [Related]
13. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
Liu HL; Huo L; Wang L
Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus.
Hu YW; Liu CY; Du CM; Zhang J; Wu WQ; Gu ZL
J Ethnopharmacol; 2009 Jun; 123(2):293-301. PubMed ID: 19429375
[TBL] [Abstract][Full Text] [Related]
16. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells.
Carbajo-Pescador S; Martín-Renedo J; García-Palomo A; Tuñón MJ; Mauriz JL; González-Gallego J
J Pineal Res; 2009 Nov; 47(4):330-8. PubMed ID: 19817970
[TBL] [Abstract][Full Text] [Related]
17. [Reversing effect of dimethyl-4,4'-dimethoxy-5,6,5'6'-dimethylenedioxybiphenyl-2,2'- dicarboxylate(DDB) on the phenotypes of human hepatocarcinoma cell line].
Liu Z; Liu G; Zhang S
Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):676-8, 710. PubMed ID: 8697089
[TBL] [Abstract][Full Text] [Related]
18. Ascorbic acid induces redifferentiation and growth inhibition in human hepatoma cells by increasing endogenous hydrogen peroxide.
Zheng QS; Zhang YT; Zheng RL
Pharmazie; 2002 Nov; 57(11):753-7. PubMed ID: 12611279
[TBL] [Abstract][Full Text] [Related]
19. Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways.
Chiang PC; Lin SC; Pan SL; Kuo CH; Tsai IL; Kuo MT; Wen WC; Chen P; Guh JH
Biochem Pharmacol; 2010 Jan; 79(2):162-71. PubMed ID: 19723512
[TBL] [Abstract][Full Text] [Related]
20. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.
Tang H; Tang XY; Liu M; Li X
Clin Chim Acta; 2008 Aug; 394(1-2):81-8. PubMed ID: 18485897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
